LEI 549300ZFES88TX3S4X20
TATAA Biocenter AB
Contract awards & public grants
Precision nutrition and postprandial immune responses → TATAA BIOCENTER AB
European Commission · SE · Grant · 2023-07-12
—
Combining optoacoustic imaging phenotypes and multi-omics to advance diabetes healthcare → TATAA BIOCENTER AB
European Commission · SE · Grant · 2020-12-16
€490,410
Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic prepa → TATAA BIOCENTER AB
European Commission · SE · Grant · 2020-04-08
€163,526
Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity → TATAA BIOCENTER AB
European Commission · SE · Grant · 2019-11-22
€1.09M
Point-of-Care implementation of TB testing with ultra-fast Local Heating PCR → TATAA BIOCENTER AB
European Commission · SE · Grant · 2017-11-09
€368,750
European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools → TATAA BIOCENTER AB
European Commission · SE · Grant · 2017-08-30
—
SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine → TATAA BIOCENTER AB
European Commission · SE · Grant · 2016-11-30
€75,448
Next generation sepsis diagnosis → TATAA BIOCENTER AB
European Commission · SE · Grant · 2015-12-09
€248,624
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.